Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

CureVac (CVAC) Earnings Date, Estimates & Call Transcripts

CureVac logo
$4.66 0.00 (0.00%)
As of 05/15/2026

CureVac Earnings Summary

CureVac released Q3 2025 earnings on November 24, 2025, reporting an EPS of -$0.10, which topped the consensus estimate of -$0.17 by $0.07. Quarterly revenue was reported to be $63.53 million, above the consensus estimate of $21.40 million. With a trailing EPS of $0.72 and a P/E Ratio of 6.47, CureVac's earnings are expected to decrease next year, from $0.72 to ($0.39) per share.

Latest Q3
Earnings Date
Nov. 24Estimated
Consensus EPS
(Nov. 24)
-$0.17
Actual EPS
(Nov. 24)
-$0.10 Beat By $0.07
Actual Revenue
(Nov. 24)
$63.53M
Get CureVac Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CureVac and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CVAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CureVac Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.72 EPS
Next Year EPS Consensus Estimate
($0.39) EPS

CureVac Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/24/2025Q3 2025-$0.17-$0.10+$0.07$1.42$21.40M$63.53M
8/21/2025Q2 2025-$0.15-$0.30 -$0.15-$0.30$4.27M$1.41M
5/22/2025Q1 2025-$0.16-$0.24 -$0.08-$0.24$4.27M$0.94M
4/10/2025Q4 2024-$0.14-$0.15 -$0.01-$0.15$6.40M$15.44M
8/15/2024Q2 2024-$0.28-$0.34 -$0.06-$0.34$10.07M$15.55M
5/23/2024Q4 2023-$0.22-$0.34 -$0.12-$0.34$14.51M$13.43M

Data powered by Fiscal.ai.

CureVac Earnings - Frequently Asked Questions

CureVac (NASDAQ:CVAC) last announced its quarterly earning data on Monday, November 24, 2025. Learn more on CVAC's earnings history.

In the previous quarter, CureVac (NASDAQ:CVAC) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.07. Learn more on analysts' earnings estimate vs. CVAC's actual earnings.

CureVac (NASDAQ:CVAC) has a recorded annual revenue of $70.74 million.

CureVac (NASDAQ:CVAC) has a recorded net income of $175.50 million. CVAC has generated $0.72 earnings per share over the last four quarters.

CureVac (NASDAQ:CVAC) has a trailing price-to-earnings ratio of 6.47 and a forward price-to-earnings ratio of 6.47.

CureVac's earnings are expected to decrease from $0.72 per share to ($0.39) per share in the next year.


This page (NASDAQ:CVAC) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners